NYSE, HSP - Hospira Inc
Hospira, Inc. ("Hospira") is a global specialty pharmaceutical and
medication delivery company that is focused on products that improve the safety,
cost and productivity of patient care. Hospira is a leader in the development,
manufacture and marketing of specialty injectable pharmaceuticals and medication
delivery systems that deliver drugs and intravenous ("I.V.") fluids. Hospira is
also a leading provider of contract manufacturing services to proprietary
pharmaceutical and biotechnology companies for formulation development, filling
and finishing of injectable pharmaceuticals. Hospira's broad portfolio of
products is used by hospitals and alternate site providers, such as clinics,
home healthcare providers and long-term care facilities.
In 2007, Hospira's net sales were $3,436.2 million, on which it earned net
income of $136.8 million. The United States is the largest market for Hospira's
products and accounted for approximately 69% of 2007 sales. ...
Read SEC Filing on NASDAQ.com »